Hypomorphic Brca2 and Rad51c double mutant mice display Fanconi anemia, cancer and polygenic replication stress

被引:0
|
作者
Karl-Heinz Tomaszowski
Sunetra Roy
Carolina Guerrero
Poojan Shukla
Caezaan Keshvani
Yue Chen
Martina Ott
Xiaogang Wu
Jianhua Zhang
Courtney D. DiNardo
Detlev Schindler
Katharina Schlacher
机构
[1] The University of Texas MD Anderson Cancer Center,Department of Cancer Biology
[2] The University of Texas MD Anderson Cancer Center,Department of Neurosurgery
[3] The University of Texas MD Anderson Cancer Center,Department of Genomic Medicine
[4] The University of Texas MD Anderson Cancer Center,Department of Leukemia
[5] University of Wuerzburg,Institut fuer Humangenetik
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The prototypic cancer-predisposition disease Fanconi Anemia (FA) is identified by biallelic mutations in any one of twenty-three FANC genes. Puzzlingly, inactivation of one Fanc gene alone in mice fails to faithfully model the pleiotropic human disease without additional external stress. Here we find that FA patients frequently display FANC co-mutations. Combining exemplary homozygous hypomorphic Brca2/Fancd1 and Rad51c/Fanco mutations in mice phenocopies human FA with bone marrow failure, rapid death by cancer, cellular cancer-drug hypersensitivity and severe replication instability. These grave phenotypes contrast the unremarkable phenotypes seen in mice with single gene-function inactivation, revealing an unexpected synergism between Fanc mutations. Beyond FA, breast cancer-genome analysis confirms that polygenic FANC tumor-mutations correlate with lower survival, expanding our understanding of FANC genes beyond an epistatic FA-pathway. Collectively, the data establish a polygenic replication stress concept as a testable principle, whereby co-occurrence of a distinct second gene mutation amplifies and drives endogenous replication stress, genome instability and disease.
引用
收藏
相关论文
共 41 条
  • [1] Hypomorphic Brca2 and Rad51c double mutant mice display Fanconi anemia, cancer and polygenic replication stress
    Tomaszowski, Karl-Heinz
    Roy, Sunetra
    Guerrero, Carolina
    Shukla, Poojan
    Keshvani, Caezaan
    Chen, Yue
    Ott, Martina
    Wu, Xiaogang
    Zhang, Jianhua
    DiNardo, Courtney D.
    Schindler, Detlev
    Schlacher, Katharina
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [2] Author Correction: Hypomorphic Brca2 and Rad51c double mutant mice display Fanconi anemia, cancer and polygenic replication stress
    Karl-Heinz Tomaszowski
    Sunetra Roy
    Carolina Guerrero
    Poojan Shukla
    Caezaan Keshvani
    Yue Chen
    Martina Ott
    Xiaogang Wu
    Jianhua Zhang
    Courtney D. DiNardo
    Detlev Schindler
    Katharina Schlacher
    Nature Communications, 15
  • [3] Hypomorphic Brca2 and Rad51c double mutant mice display Fanconi anemia, cancer and polygenic replication stress (vol 15, 2214 , 2024)
    Tomaszowski, Karl-Heinz
    Roy, Sunetra
    Guerrero, Carolina
    Shukla, Poojan
    Keshvani, Caezaan
    Chen, Yue
    Ott, Martina
    Wu, Xiaogang
    Zhang, Jianhua
    Dinardo, Courtney D.
    Schindler, Detlev
    Schlacher, Katharina
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [4] Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations
    Ahlborn, Lise B.
    Steffensen, Ane Y.
    Jonson, Lars
    Djursby, Malene
    Nielsen, Finn C.
    Gerdes, Anne-Marie
    Hansen, Thomas V. O.
    FAMILIAL CANCER, 2015, 14 (01) : 129 - 133
  • [5] Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations
    Lise B. Ahlborn
    Ane Y. Steffensen
    Lars Jønson
    Malene Djursby
    Finn C. Nielsen
    Anne-Marie Gerdes
    Thomas V. O. Hansen
    Familial Cancer, 2015, 14 : 129 - 133
  • [6] Nuclear localization of Rad51B is independent of Rad51C and BRCA2
    Miller, KA
    Hinz, JM
    Yamada, NA
    Thompson, LH
    Albala, JS
    MUTAGENESIS, 2005, 20 (01) : 57 - 63
  • [7] Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2 and RAD51C Status
    J. M. Cunningham
    M. S. Cicek
    N. B. Larson
    J. Davila
    C. Wang
    M. C. Larson
    H. Song
    E. M. Dicks
    P. Harrington
    M. Wick
    B. J. Winterhoff
    H. Hamidi
    G. E. Konecny
    J. Chien
    M. Bibikova
    J.-B. Fan
    K. R. Kalli
    N. M. Lindor
    B. L. Fridley
    P. P. D. Pharoah
    E. L. Goode
    Scientific Reports, 4
  • [8] Clinical Characteristics of Ovarian Cancer Classified by BRCA1, BRCA2, and RAD51C Status
    Cunningham, J. M.
    Cicek, M. S.
    Larson, N. B.
    Davila, J.
    Wang, C.
    Larson, M. C.
    Song, H.
    Dicks, E. M.
    Harrington, P.
    Wick, M.
    Winterhoff, B. J.
    Hamidi, H.
    Konecny, G. E.
    Chien, J.
    Bibikova, M.
    Fan, J. -B.
    Kalli, K. R.
    Lindor, N. M.
    Fridley, B. L.
    Pharoah, P. P. D.
    Goode, E. L.
    SCIENTIFIC REPORTS, 2014, 4
  • [9] RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer
    Somyajit, Kumar
    Subramanya, Shreelakshmi
    Nagaraju, Ganesh
    CARCINOGENESIS, 2010, 31 (12) : 2031 - 2038
  • [10] Characterising cancer risks for carriers of mutations in BRCA1, BRCA2, PALB2, and RAD51C genes
    Antoniou, Antonis C.
    CANCER RESEARCH, 2015, 75